# Titan Machinery Inc.: financial statements, quarterly

TITN · Nasdaq · CIK 1409171 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/titn.md) · [Financials](/companies/titn/financials.md) · [Filings](/companies/titn/filings.md) · [Insiders](/companies/titn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/titn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [694](/filings/0001409171-24-000106.md) | [852 d](/filings/0001628280-26-022376.md) | [629](/filings/0001409171-25-000072.md) | [634](/filings/0001409171-25-000083.md) | [680](/filings/0001628280-25-055360.md) | [760 d](/filings/0001409171-25-000027.md) | [594](/filings/0001628280-26-041821.md) | [546](/filings/0001628280-26-060350.md) | [645](/filings/0001628280-25-055360.md) | [642 d](/filings/0001628280-26-022376.md) | [522](/filings/0001628280-26-041821.md) | [496](/filings/0001628280-26-060350.md) |
| Cost of revenue | $m | [556](/filings/0001409171-24-000106.md) | [711 d](/filings/0001628280-26-022376.md) | [507](/filings/0001409171-25-000072.md) | [521](/filings/0001409171-25-000083.md) | [569](/filings/0001628280-25-055360.md) | [709 d](/filings/0001628280-26-022376.md) | [503](/filings/0001628280-26-041821.md) | [453](/filings/0001628280-26-060350.md) | [533](/filings/0001628280-25-055360.md) | [555 d](/filings/0001628280-26-022376.md) | [433](/filings/0001628280-26-041821.md) | [404](/filings/0001628280-26-060350.md) |
| Gross profit | $m | [138](/filings/0001409171-24-000106.md) | [141 d](/filings/0001628280-26-022376.md) | [122](/filings/0001409171-25-000072.md) | [112](/filings/0001409171-25-000083.md) | [110](/filings/0001628280-25-055360.md) | [51.0 d](/filings/0001628280-26-022376.md) | [90.9](/filings/0001628280-26-041821.md) | [93.6](/filings/0001628280-26-060350.md) | [111](/filings/0001628280-25-055360.md) | [87.0 d](/filings/0001628280-26-022376.md) | [89.3](/filings/0001628280-26-041821.md) | [92.4](/filings/0001628280-26-060350.md) |
| Operating income | $m | [46.2](/filings/0001409171-24-000106.md) | [40.7 d](/filings/0001628280-26-022376.md) | [22.6](/filings/0001409171-25-000072.md) | [15.8](/filings/0001409171-25-000083.md) | [11.5](/filings/0001628280-25-055360.md) | [(45.8) d](/filings/0001628280-26-022376.md) | [(5.7)](/filings/0001628280-26-041821.md) | [0.7](/filings/0001628280-26-060350.md) | [10.3](/filings/0001628280-25-055360.md) | [(11.9) d](/filings/0001628280-26-022376.md) | [(5.6)](/filings/0001628280-26-041821.md) | [(2.3)](/filings/0001628280-26-060350.md) |
| Income tax | $m | [10.3](/filings/0001409171-24-000106.md) | [9.6 d](/filings/0001628280-26-022376.md) | [3.3](/filings/0001409171-25-000072.md) | [0.1](/filings/0001409171-25-000083.md) | [(1.4)](/filings/0001628280-25-055360.md) | [(15.0) d](/filings/0001628280-26-022376.md) | [(4.1)](/filings/0001628280-26-041821.md) | [(2.2)](/filings/0001628280-26-060350.md) | [1.6](/filings/0001628280-25-055360.md) | [13.5 d](/filings/0001628280-26-022376.md) | [0.1](/filings/0001628280-26-041821.md) | [(0.0)](/filings/0001628280-26-060350.md) |
| Net income | $m | [30.2](/filings/0001409171-24-000106.md) | [24.0 d](/filings/0001628280-26-022376.md) | [9.4](/filings/0001628280-25-055360.md) | [(4.3)](/filings/0001628280-25-055360.md) | [1.7](/filings/0001628280-25-055360.md) | [(43.8) d](/filings/0001628280-26-022376.md) | [(13.2)](/filings/0001628280-26-060350.md) | [(6.0)](/filings/0001628280-26-060350.md) | [1.2](/filings/0001628280-25-055360.md) | [(36.2) d](/filings/0001628280-26-022376.md) | [(12.6)](/filings/0001628280-26-060350.md) | [(9.2)](/filings/0001628280-26-060350.md) |
| Diluted EPS | $ per share | [1.32](/filings/0001409171-24-000106.md) | not reported | [0.41](/filings/0001409171-25-000072.md) | [(0.19)](/filings/0001409171-25-000083.md) | [0.07](/filings/0001628280-25-055360.md) | not reported | [(0.58)](/filings/0001628280-26-041821.md) | [(0.26)](/filings/0001628280-26-060350.md) | [0.05](/filings/0001628280-25-055360.md) | not reported | [(0.55)](/filings/0001628280-26-041821.md) | [(0.40)](/filings/0001628280-26-060350.md) |
| Basic EPS | $ per share | [1.32](/filings/0001409171-24-000106.md) | not reported | [0.41](/filings/0001409171-25-000072.md) | [(0.19)](/filings/0001409171-25-000083.md) | [0.07](/filings/0001628280-25-055360.md) | not reported | [(0.58)](/filings/0001628280-26-041821.md) | [(0.26)](/filings/0001628280-26-060350.md) | [0.05](/filings/0001628280-25-055360.md) | not reported | [(0.55)](/filings/0001628280-26-041821.md) | [(0.40)](/filings/0001628280-26-060350.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [70.0](/filings/0001409171-23-000085.md) | [38.1](/filings/0001409171-25-000027.md) | [35.7](/filings/0001409171-24-000081.md) | [31.2](/filings/0001409171-24-000098.md) | [23.4](/filings/0001409171-24-000106.md) | [35.9](/filings/0001628280-26-022376.md) | [21.5](/filings/0001409171-25-000072.md) | [32.7](/filings/0001409171-25-000083.md) | [48.8](/filings/0001628280-25-055360.md) | [28.2](/filings/0001628280-26-060350.md) | [29.6](/filings/0001628280-26-041821.md) | [29.5](/filings/0001628280-26-060350.md) |
| Current assets | $m | [1,286](/filings/0001409171-23-000085.md) | [1,519](/filings/0001409171-25-000027.md) | [1,615](/filings/0001409171-24-000081.md) | [1,709](/filings/0001409171-24-000098.md) | [1,597](/filings/0001409171-24-000106.md) | [1,293](/filings/0001628280-26-022376.md) | [1,273](/filings/0001409171-25-000072.md) | [1,326](/filings/0001409171-25-000083.md) | [1,228](/filings/0001628280-25-055360.md) | [1,090](/filings/0001628280-26-060350.md) | [1,085](/filings/0001628280-26-041821.md) | [1,101](/filings/0001628280-26-060350.md) |
| Total assets | $m | [1,650](/filings/0001409171-23-000085.md) | [1,992](/filings/0001628280-26-022376.md) | [2,088](/filings/0001409171-24-000081.md) | [2,221](/filings/0001409171-24-000098.md) | [2,109](/filings/0001409171-24-000106.md) | [1,814](/filings/0001628280-26-022376.md) | [1,798](/filings/0001409171-25-000072.md) | [1,878](/filings/0001409171-25-000083.md) | [1,769](/filings/0001628280-25-055360.md) | [1,617](/filings/0001628280-26-060350.md) | [1,615](/filings/0001628280-26-041821.md) | [1,629](/filings/0001628280-26-060350.md) |
| Current liabilities | $m | [885](/filings/0001409171-23-000085.md) | [1,152](/filings/0001409171-25-000027.md) | [1,248](/filings/0001409171-24-000081.md) | [1,343](/filings/0001409171-24-000098.md) | [1,212](/filings/0001409171-24-000106.md) | [961](/filings/0001628280-26-022376.md) | [956](/filings/0001409171-25-000072.md) | [1,011](/filings/0001409171-25-000083.md) | [904](/filings/0001628280-25-055360.md) | [772](/filings/0001628280-26-060350.md) | [788](/filings/0001628280-26-041821.md) | [818](/filings/0001628280-26-060350.md) |
| Long-term debt | $m | [87.6](/filings/0001409171-23-000085.md) | [106](/filings/0001409171-25-000027.md) | [105](/filings/0001409171-24-000081.md) | [117](/filings/0001409171-24-000098.md) | [131](/filings/0001409171-24-000106.md) | [158](/filings/0001628280-26-022376.md) | [154](/filings/0001409171-25-000072.md) | [153](/filings/0001409171-25-000083.md) | [155](/filings/0001628280-25-055360.md) | [159](/filings/0001628280-26-060350.md) | [151](/filings/0001628280-26-041821.md) | [147](/filings/0001628280-26-060350.md) |
| Current portion of debt | $m | [11.6](/filings/0001409171-23-000085.md) | [13.7](/filings/0001409171-25-000027.md) | [13.9](/filings/0001409171-24-000081.md) | [9.9](/filings/0001409171-24-000098.md) | [9.5](/filings/0001409171-24-000106.md) | [10.9](/filings/0001628280-26-022376.md) | [11.4](/filings/0001409171-25-000072.md) | [11.4](/filings/0001409171-25-000083.md) | [21.8](/filings/0001628280-25-055360.md) | [21.4](/filings/0001628280-26-060350.md) | [26.1](/filings/0001628280-26-041821.md) | [25.9](/filings/0001628280-26-060350.md) |
| Shareholders' equity | $m | [626](/filings/0001409171-24-000106.md) | [658](/filings/0001628280-26-022376.md) | [663](/filings/0001628280-25-055360.md) | [660](/filings/0001628280-25-055360.md) | [668](/filings/0001628280-25-055360.md) | [614](/filings/0001628280-26-060350.md) | [605](/filings/0001628280-26-060350.md) | [610](/filings/0001628280-26-060350.md) | [613](/filings/0001628280-25-055360.md) | [579](/filings/0001628280-26-060350.md) | [566](/filings/0001628280-26-060350.md) | [558](/filings/0001628280-26-060350.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [40.6 d](/filings/0001409171-24-000106.md) | [49.8 d](/filings/0001628280-26-022376.md) | [(32.4)](/filings/0001409171-25-000072.md) | [(15.0) d](/filings/0001409171-25-000083.md) | [(8.8) d](/filings/0001628280-25-055360.md) | [126 d](/filings/0001628280-26-022376.md) | [6.2](/filings/0001628280-26-041821.md) | [43.7 d](/filings/0001628280-26-060350.md) | [34.0 d](/filings/0001628280-25-055360.md) | [53.6 d](/filings/0001628280-26-022376.md) | [(23.1)](/filings/0001628280-26-041821.md) | [(2.0) d](/filings/0001628280-26-060350.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.4](/filings/0001409171-23-000085.md) | [22.4](/filings/0001409171-24-000081.md) | [22.5](/filings/0001409171-24-000098.md) | [22.5](/filings/0001409171-24-000106.md) | [22.5](/filings/0001409171-25-000072.md) | [22.6](/filings/0001409171-25-000083.md) | [22.6](/filings/0001628280-25-055360.md) | [22.7](/filings/0001628280-26-041821.md) | [22.8](/filings/0001628280-26-060350.md) | [22.8](/filings/0001628280-25-055360.md) | [22.8](/filings/0001628280-26-041821.md) | [23.0](/filings/0001628280-26-060350.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 23,532,897 at 2026-08-31, from the cover of the [10-Q filed 2026-09-03](/filings/0001628280-26-060350.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.